Home
Forms Library
(aflibercept) Injectable Medication Precertification Request (aflibercept) Injectable Medication Pre

(aflibercept) Injectable Medication Precertification Request (aflibercept) Injectable Medication Pre 2025

(aflibercept) Injectable Medication Precertification Request (aflibercept) Injectable Medication Pre Preview on Page 1

Show details

4.4 out of 5

61 votes

The document is a precertification request form for Eylea® (aflibercept) injectable medication, intended for patients requiring treatment for various eye conditions such as neovascular age-related macular degeneration and diabetic macular edema. It includes sections for patient and prescriber information, insurance details, clinical information, and required documentation to support the request.

Here's how it works

01. Edit your form online

Type text, add images, blackout confidential details, add comments, highlights and more.

02. Sign it in a few clicks

Draw your signature, type it, upload its image, or use your mobile device as a signature pad.

03. Share your form with others

Send it via email, link, or fax. You can also download it, export it or print it out.

How to rapidly redact (aflibercept) Injectable Medication Precertification Request (aflibercept) Injectable Medication Pre online

Ease of Setup

DocHub User Ratings on G2

Ease of Use

DocHub User Ratings on G2

Dochub is a perfect editor for updating your documents online. Adhere to this straightforward guide to edit (aflibercept) Injectable Medication Precertification Request (aflibercept) Injectable Medication Pre in PDF format online at no cost:

Sign up and sign in. Register for a free account, set a secure password, and proceed with email verification to start managing your forms.
Add a document. Click on New Document and select the file importing option: add (aflibercept) Injectable Medication Precertification Request (aflibercept) Injectable Medication Pre from your device, the cloud, or a protected link.
Make changes to the sample. Take advantage of the upper and left-side panel tools to change (aflibercept) Injectable Medication Precertification Request (aflibercept) Injectable Medication Pre. Add and customize text, images, and fillable fields, whiteout unnecessary details, highlight the significant ones, and provide comments on your updates.
Get your paperwork accomplished. Send the form to other people via email, generate a link for faster file sharing, export the sample to the cloud, or save it on your device in the current version or with Audit Trail added.

Try all the advantages of our editor right now!

See more (aflibercept) Injectable Medication Precertification Request (aflibercept) Injectable Medication Pre versions

We've got more versions of the (aflibercept) Injectable Medication Precertification Request (aflibercept) Injectable Medication Pre form. Select the right (aflibercept) Injectable Medication Precertification Request (aflibercept) Injectable Medication Pre version from the list and start editing it straight away!

Versions	Form popularity	Fillable & printable
2022	4.8 Satisfied (64 Votes)
2021	4.1 Satisfied (49 Votes)
2020	4.3 Satisfied (64 Votes)
2020	4.4 Satisfied (95 Votes)
2018	4.2 Satisfied (133 Votes)
2017	4.4 Satisfied (61 Votes)

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.

What is the new FDA approved eye injection?

Basel, 04 February 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema (DME), a leading cause of vision loss in adults with diabetes, affecting more than 29 million

What are the guidelines for Eylea?

The recommended dose of EYLEA for Diabetic Retinopathy is 2 mg administered by injection in the eye every 4 weeks (approximately every 28 days, monthly) for the first 5 months, followed by 1 injection every 8 weeks (2 months). Some patients may need every 4-week (monthly) dosing after the first 20 weeks (5 months).

What is aflibercept injection used for?

Aflibercept injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes blurred vision or blindness. Aflibercept works by changing the amount of blood that gets to the retina.

Is aflibercept FDA approved?

The FDA announced that it approved the first 2 biosimilars referencing Eylea (aflibercept) for the treatment of ophthalmic conditions, including neovascular age-related macular degeneration (AMD), macular edema, and diabetic retinopathy.

What is the success rate of the Eylea injection?

For diabetic macular edema specifically, 58% of patients had an improvement in their visual acuity measurements at 6 months compared to 6% in the control group. At one year, 80% of patients receiving Eylea improved compared to 15% in the control group.

Is the aflibercept injection approved by the FDA?

(NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA HD (aflibercept) Injection 8 mg for the treatment of patients with wet age-related macular degeneration (wAMD), diabetic macular edema (DME) and diabetic retinopathy (DR).

What is the average cost of Eylea per injection?

The cost for Eylea (40 mg/mL) intravitreal solution is around $1,989 for a supply of 0.05 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans.

(aflibercept) Injectable Medication Precertification Request (aflibercept) Injectable Medication Pre 2025

Here's how it works

How to rapidly redact (aflibercept) Injectable Medication Precertification Request (aflibercept) Injectable Medication Pre online